MoneyWorks4Me

Vaishali Pharma - Quaterly Results

11 Aug 2025 Evaluate
The sales for the June 2025 quarter moved up 31.34% to Rs. 237.47 millions as compared to Rs. 180.80 millions during the corresponding quarter last year.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 12.81  millions as against Rs. 16.99 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 22.11 millions from 27.68 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 237.47 180.80 31.34 237.47 180.80 31.34 990.26 862.80 14.77
Other Income 8.43 4.24 98.82 8.43 4.24 98.82 32.05 20.34 57.57
PBIDT 22.11 27.68 -20.12 22.11 27.68 -20.12 32.95 31.71 3.91
Interest 3.32 3.79 -12.40 3.32 3.79 -12.40 15.83 17.37 -8.87
PBDT 18.79 23.89 -21.35 18.79 23.89 -21.35 17.12 14.34 19.39
Depreciation 1.42 1.19 19.33 1.42 1.19 19.33 4.87 5.08 -4.13
PBT 17.37 22.70 -23.48 17.37 22.70 -23.48 12.25 9.26 32.29
TAX 4.56 5.71 -20.14 4.56 5.71 -20.14 4.08 2.07 97.10
Deferred Tax 0.19 0.00 0.00 0.19 0.00 0.00 -0.09 -0.40 -77.50
PAT 12.81 16.99 -24.60 12.81 16.99 -24.60 8.17 7.19 13.63
Equity 260.92 120.94 115.74 260.92 120.94 115.74 260.92 107.19 143.42
PBIDTM(%) 9.31 15.31 -39.18 9.31 15.31 -39.18 3.33 3.68 -9.46
Peers